TipRanks
Lifeline Biotechnologies Inc (LLBO)
OTHER OTC:LLBO
US Market

Lifeline Biotechnologies (LLBO) Ratios

35 Followers

Lifeline Biotechnologies Ratios

See a summary of LLBO’s cash flow.
Ratios
Dec 18Dec 17
Liquidity Ratios
Current Ratio
― 0.46
Quick Ratio
― 0.46
Cash Ratio
― <0.01
Solvency Ratio
― 0.31
Operating Cash Flow Ratio
― 0.36
Short-Term Operating Cash Flow Coverage
― 0.43
Net Current Asset Value
$ ―$ -207.97K
Leverage Ratios
Debt-to-Assets Ratio
― 0.74
Debt-to-Equity Ratio
― 5.93
Debt-to-Capital Ratio
― 0.86
Long-Term Debt-to-Capital Ratio
― 0.00
Financial Leverage Ratio
― 7.99
Debt Service Coverage Ratio
― -0.13
Interest Coverage Ratio
― 0.00
Debt to Market Cap
― 0.03
Interest Debt Per Share
― <0.01
Net Debt to EBITDA
― -7.53
Profitability Margins
Gross Profit Margin
―0.00%
EBIT Margin
―0.00%
EBITDA Margin
―0.00%
Operating Profit Margin
―0.00%
Pretax Profit Margin
―0.00%
Net Profit Margin
―0.00%
Continuous Operations Profit Margin
―0.00%
Net Income Per EBT
―100.00%
EBT Per EBIT
―100.00%
Return on Assets (ROA)
―-9.84%
Return on Equity (ROE)
―-78.59%
Return on Capital Employed (ROCE)
―-78.60%
Return on Invested Capital (ROIC)
―-11.35%
Return on Tangible Assets
―-9.84%
Earnings Yield
―-0.43%
Efficiency Ratios
Receivables Turnover
― 0.00
Payables Turnover
― 0.00
Inventory Turnover
― 0.00
Fixed Asset Turnover
― 0.00
Asset Turnover
― 0.00
Working Capital Turnover Ratio
― 0.00
Cash Conversion Cycle
― 0.00
Days of Sales Outstanding
― 0.00
Days of Inventory Outstanding
― 0.00
Days of Payables Outstanding
― 0.00
Operating Cycle
― 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
― <0.01
Free Cash Flow Per Share
― <0.01
CapEx Per Share
― 0.00
Free Cash Flow to Operating Cash Flow
― 1.00
Dividend Paid and CapEx Coverage Ratio
― 0.00
Capital Expenditure Coverage Ratio
― 0.00
Operating Cash Flow Coverage Ratio
― 0.43
Operating Cash Flow to Sales Ratio
― 0.00
Free Cash Flow Yield
―1.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
― -231.50
Price-to-Sales (P/S) Ratio
― 0.00
Price-to-Book (P/B) Ratio
― 181.95
Price-to-Free Cash Flow (P/FCF) Ratio
― 71.84
Price-to-Operating Cash Flow Ratio
― 71.84
Price-to-Earnings Growth (PEG) Ratio
― 2.03
Price-to-Fair Value
― 181.95
Enterprise Value Multiple
― -239.02
Enterprise Value
― 10.37M
EV to EBITDA
― -239.02
EV to Sales
― 0.00
EV to Free Cash Flow
― 74.17
EV to Operating Cash Flow
― 74.17
Tangible Book Value Per Share
― <0.01
Shareholders’ Equity Per Share
― <0.01
Tax and Other Ratios
Effective Tax Rate
― 0.00
Revenue Per Share
― 0.00
Net Income Per Share
― >-0.01
Tax Burden
― 1.00
Interest Burden
― 1.00
Research & Development to Revenue
― 0.00
SG&A to Revenue
― 0.00
Stock-Based Compensation to Revenue
― 0.00
Income Quality
― -3.22
Currency in USD